Patients in Phenogroup4 had the highest prevalence of ischemic etiology, smoking and chronic lung disease, the most symptoms, as well as highest NT-proBNP and troponin levels (Woolley et al., 2021[131]). This evidence concerns the gene NPPB and chronic lung disease.